Wearables in Clinical Workflows: Which Signals Actually Matter

Wearables generate vastly more data than clinicians can usefully consume. Heart rate every minute, sleep stages every night, activity continuously, and now in many devices ECG, blood oxygen, skin temperature, and HRV. The clinically actionable subset is much narrower than the data volume suggests, and most of the value comes from a few specific patterns.

What’s actually useful and how to ingest it cleanly.

The signals that matter clinically#

Atrial fibrillation detection (Apple Watch, Fitbit). Useful for stroke prevention in undetected AFib; FDA-cleared for some devices.

Resting heart rate trends. Rising RHR over days/weeks correlates with early infection, overtraining, decompensation. Useful in chronic-disease cohorts.

Sleep duration and disruption. Tightly correlated with mental health, recovery, chronic disease management.

Activity baseline and decline. Sudden activity drops are early frailty/decline signals in elderly populations.

Continuous glucose monitoring (CGM) in diabetes. The most clinically validated wearable category.

Blood pressure from FDA-cleared cuffs (still the dominant modality; watch-based BP is improving but not yet authoritative).

Pulse oximetry for relevant conditions (COPD, sleep apnea, COVID-era acute illness monitoring).

The rest — calorie counts, stress scores, “readiness” scores, mood tracking — is engagement data, not clinical signal.

The data-ingestion challenge#

Each device vendor has its own API, authorization model, and data structure. The path that works:

• Use a third-party aggregator (Validic, Human API, Spike API, Health Gorilla) for breadth — accepts trade-off of paying per record
• Direct integration with Apple HealthKit / Google Fit for major coverage of consumer wearables
• Direct device APIs for high-volume specific devices (Dexcom for CGM, etc.)
• Manual entry as fallback

Vendor sprawl is real. Standardize on a few sources.

The “what to do with it” problem#

Once ingested, the question is what triggers a clinical action. Options:

Rule-based thresholds. Per-patient (or per-population) thresholds on key signals. Crude but transparent.

Personalized baselines. Each patient’s own normal range; deviations trigger investigation.

ML-based anomaly detection. Catches patterns rule-based thresholds miss. Higher false-positive risk.

Risk-stratification cohorts. Combine wearable signals with EHR data to identify cohorts needing outreach.

The deployments that work pick a specific clinical question (“who in my CHF cohort is decompensating?”) and tune the wearable signal use to that question. Generic “monitor everything” produces alert fatigue.

Where wearables don’t earn their clinical place#

Healthy populations without monitoring indication. Engagement value; limited clinical value.

Replacing measured clinical data. Watch-based BP doesn’t replace cuff BP for hypertension management.

Continuous surveillance as a substitute for clinical relationship. Patients with chronic conditions need humans plus data.

The integration question#

Wearable data must flow into:

• The EHR (with appropriate filtering — don’t dump every heart rate sample)
• The care team’s workflow (single inbox)
• Patient-facing summaries

Our data engineering practice builds these ingestion and integration pipelines for health systems.

What we ship for healthcare clients#

For wearable-integration engagements:

• Multi-vendor ingestion (aggregator + HealthKit + direct for key devices)
• Signal-filtering policy (what’s worth surfacing)
• Patient-specific baseline computation
• EHR integration via FHIR
• Care-team alerting with clinical review

The privacy reality#

Wearable data feels less sensitive than EHR data; it isn’t. Continuous heart rate, sleep, location, activity is genuinely revealing. Treat it with the same protections as the rest of the patient record.

We’ve audited several health-system wearable pilots where wearable data ended up in less-protected systems than the EHR. Don’t do that.

The 2026 outlook#

The clinically validated set of wearable signals is growing slowly. The hype around wearable-driven AI care is still ahead of the clinical evidence in most cases. The deployments that earn their place stay tightly focused on validated signals and specific clinical questions.

---

Wearables earn clinical value when used for specific questions, not generic surveillance. Our team builds wearable ingestion pipelines for health systems and care programs. Tell us about the cohort.